FDA News
🇺🇸 FDA Page 6FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.
Showing 61–72 of 391 articles
Alabama Board of Medical Examiners Issues Warning on Non-FDA-Approved Peptides: What Pharma Teams Need to Know
FDA · 4 min
Dr. Sarah MitchellVertex Announces FDA Acceptance of Biologics License Application for Accelerated Approval of Povetacicept in IgA Nephropathy
FDA · IgA Nephropathy · 4 min
Dr. Sarah MitchellAurobindo Pharma OAI Classification: Implications for Drug Approvals
FDA · 5 min
Dr. Sarah MitchellLee, Tuberville Introduce Protections for Homeopathic Medicine with FDA Approval Framework
FDA · 4 min
Dr. Sarah MitchellFDA Approves Ensitrelvir (XOCOVA) as First Oral Option for COVID-19 Post-Exposure Prophylaxis
FDA · COVID-19 · 5 min
Dr. Sarah MitchellFDA Priority Review Voucher Program: Will Makary's Initiative Survive?
FDA · 7 min
Dr. Sarah MitchellTexas AG Investigating Energy Drinks: What Pharma Teams Need to Know
FDA · 5 min
Dr. Sarah MitchellFDA Voucher Program Under Fire: Pharma and Patient Groups Demand Pause
FDA · 5 min
Dr. Sarah MitchellFDA Extends Comment Period for Real-Time Clinical Trials Pilot, AI Use in Studies
FDA · 6 min
Dr. Sarah MitchellFDA Approves Companion Diagnostic for Inavolisib in HR+/HER2–, PIK3CA-Mutated Breast Cancer
FDA · oncology · 5 min
Dr. Sarah MitchellThe Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means — drug approvals
FDA · 5 min
Dr. Sarah MitchellPharma Pulse: 340B Uncertainty, Drug Shortages, and Wegovy's Global Debut
FDA · 8 min
Dr. Sarah MitchellExplore intelligence